Uvax Bio receives $2.6 M funding to develop vaccine against Middle East Respiratory Syndrome

Efforts to advance the first-ever vaccine against Middle East Respiratory Syndrome (MERS) are progressing, with a new in...

March 26, 2025 | Wednesday | News
World Vaccine Congress Washington 2025 - the world's largest vaccine event; April 21-24, 2025; Registration is Open

The World Vaccine Congress Washington 2025, the largest and most influential global vaccine event, is officially open fo...

March 21, 2025 | Friday | News
Japan's GHIT invests $11.4 M for treatment of neglected tropical diseases

Japan's Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.7 b...

March 19, 2025 | Wednesday | News
WHO deploys PharmaJet’s needle-free injection system for polio eradication in Pakistan

US-based PharmaJet, a company that strives to improve the performance and outcomes of injectables with its enabling...

March 13, 2025 | Thursday | News
SK bioscience expands global reach with influenza vaccine exports to Southern Hemisphere

South Korea-based SK bioscience, a global innovative vaccine and biotech company committed to promoting human health fro...

March 13, 2025 | Thursday | News
Korea's SK bioscience secures additional PAHO contract to supply varicella vaccine to Latin America

South Korea-based SK bioscience had received prior notification from the Pan American Health Organization (PAHO), a spec...

February 28, 2025 | Friday | News
Singapore host 2nd APIC-ADVA Summit on Infectious Diseases and Immunization to build resilience

The Asia Pacific Immunization Coalition (APIC) and the Asia Dengue Voice & Action (ADVA), with the Centre for Behavi...

February 11, 2025 | Tuesday | News
SK bioscience and Sanofi expand partnership to target domestic market for RSV and Hepatitis A prevention medicines

South Korea-based SK bioscience, and global healthcare leader Sanofi, are strengthening their partnership to jointly tar...

January 23, 2025 | Thursday | News
Australia's Vaxxas advances $4.8 M programme for needle-free thermostable mRNA vaccines

Vaxxas, an Australia-based clinical-stage biotechnology company commercialising a novel high-density microarray patch (H...

January 23, 2025 | Thursday | News
Harnessing mRNA technology to tackle unmet medical needs in Asia

Asia is emerging as a hub for biopharmaceuticals and vaccine manufacturing, leveraging its strengths in manufacturing an...

January 21, 2025 | Tuesday | Opinion
UQ and Vaxxas in Australia win $2 M from US to advance patch-based mRNA COVID-19 vaccine

Australia-based University of Queensland’s (UQ) BASE facility, within the Australian Institute for Bioenginee...

January 14, 2025 | Tuesday | News
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa

In a significant step toward enhancing vaccine self-sufficiency and pandemic preparedness in Africa, TechInvention, an I...

January 6, 2025 | Monday | News
SK bioscience inks KRW 75.5 B deal with Sanofi to develop next-gen pneumococcal conjugate vaccines

South Korea-based SK bioscience and French pharmaceutical firm Sanofi have announced the signing of an expanded agreem...

December 23, 2024 | Monday | News
Building vaccine and therapeutics manufacturing capacity in Asia Pacific

Scientists from Australia's Biomedical Manufacturing Programme are partnering with Thailand and Malaysia to en...

December 20, 2024 | Friday | News
Consortium set to further establish vaccine safety evidence-generation network in Africa

A research consortium is set to further establish a vaccine safety evidence-generation network in Africa, seeking to und...

December 17, 2024 | Tuesday | News
Korea's SK bioscience gets approval for global clinical trials of mRNA Japanese Encephalitis Vaccine candidate

South Korea-based SK bioscience, a global innovative vaccine and biotech company, has received approval from the Human R...

December 13, 2024 | Friday | News
Moderna officially opens new vaccine manufacturing facility in Australia

Moderna has officially launched its new vaccine manufacturing facility at Monash University’s Clayton campus in so...

December 10, 2024 | Tuesday | News
Hong Kong approves Pfizer's 20-valent Pneumococcal Conjugate Vaccine for infants and children

American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved the company...

December 3, 2024 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls